Jonathan Oh
Augusta University(US)Texas Oncology(US)Cancer Research Center(US)Methodist Hospital(US)Broward Health(US)Arizona Oncology(US)Billings Clinic(US)
Publications by Year
Research Areas
Cancer Research and Treatments, Immunotherapy and Immune Responses, Ovarian cancer diagnosis and treatment, Virus-based gene therapy research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer(2011)193 cited
- → Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial(2020)112 cited
- → Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer(2016)88 cited
- → Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance(2020)21 cited
- → Randomized double-blind placebo-controlled trial of primary maintenance vigil immunotherapy (VITAL study) in stage III/IV ovarian cancer: Efficacy assessment in BRCA1/2-wt patients.(2020)5 cited
- → Clinical trial in progress: A phase 3 study of maintenance bi-shRNA-furin/GM-CSF-expressing autologous tumor cell vaccine in women with stage IIIb-IV high-grade epithelial ovarian cancer.